OTREXUP 17.5 MG/0.4 ML AUTOINJ

methotrexate
$476.9600per ML
High Outlier

Strength

17.5 mg/.4mL

NDC

54436001704

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/1/2025

Active Ingredients

METHOTREXATE

Approval Type

New Drug (NDA)

FDA Application

NDA204824

On Market Since

10/11/2013

Pharmacological Classes

Folate Analog Metabolic Inhibitor
Folic Acid Metabolism Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+2.9%

Generic Alternatives

Save up to 14%

1 alternative • Same active ingredient